JGC
AMAG

J. Goldman & Co’s AMAG Pharmaceuticals AMAG Stock Holding History

J. Goldman & Co’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-151,378
Closed -$3.05M – 495
2018
Q1 		$3.05M Buy
+151,378
New +$2.56M 0.13% 175
2015
Q2 		– Sell
-11,500
Closed -$629K – 358
2015
Q1 		$629K Buy
+11,500
New +$548K 0.04% 241
2014
Q4 		– Sell
-102,500
Closed -$3.27M – 307
2014
Q3 		$3.27M Sell
102,500
-37,500
-27% -$800K 0.2% 138
2014
Q2 		$2.9M Sell
140,000
-475,500
-77% -$8.79M 0.21% 120
2014
Q1 		$11.9M Buy
615,500
+459,200
+294% +$9.75M 0.88% 20
2013
Q4 		$3.79M Buy
+156,300
New +$3.68M 0.48% 65

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

J. Goldman & Co's AMAG Position: Q2 2018 in Review

J. Goldman & Co sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 151,378 shares — an estimated $3.05M sold.

J. Goldman & Co first reported a position in AMAG in Q4 2013 and held it in 6 quarters. The position peaked at $11.9M in Q1 2014. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • J. Goldman & Co reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • J. Goldman & Co sold 151,378 AMAG Pharmaceuticals shares in Q2 2018, an estimated $3.05M.
  • J. Goldman & Co first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • J. Goldman & Co's AMAG Pharmaceuticals position peaked at $11.9M in Q1 2014.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on J. Goldman & Co's 13F filing for Q2 2018, filed 14 Aug 2018.